M. Gaga (Athens, Greece), M. Hoegman (Gavle, Sweden)
Impact of the trumpet and axial diffusion model on alveolar nitric oxide levels in smokers with asthma
M. Spears, C. Weir, J. Thompson, M. Brannigan, R. Chaudhuri, J. Lafferty, E. Cameron, N. Thomson (Glasgow, United Kingdom)
|  |
Diurnal variation of exhaled, alveolar and nasal NO in healthy subjects
A. Malinovschi, P. Kalm-Stephens, L. Nordvall, K. Alving (Uppsala, Sweden)
| |
Mechanisms of decrease in fractional exhaled nitric oxide during acute bronchoconstriction
G. Guarnieri, I. Cattoni, P. Mason, M. C. Scarpa, P. Maestrelli (Padova, Italy)
| |
Exhaled NO is independently related to the degree of allergic sensitisation and bronchial resposiveness in atopic subjects
A. Malinovschi, G. Rolla, D. Norbäck, M. Högman, K. Torén, A. C. Olin, C. Janson (Uppsala, Gothenburg, Sweden; Turin, Italy)
| |
In current smokers fraction of exhaled nitric oxide is not associated with asthma symptoms
A. C. Olin, A. Rosengren, K. Torén (Gothenburg, Sweden)
| |
Long-term, seasonal and diurnal variation of fractional exhaled nitric oxide
M. Andersson, K. Wass, J. Nilsson, B. Forsberg, A. C. Olin (Umeå, Sweden)
| |
Relationship between fractional exhaled nitric oxide and nasal symptom in allergic rhinitis
M. Fujii, H. Tanaka, J. Kitada, H. Shirasaki, T. Himi, H. Takahashi (Japan)
| |
Effect of salbutamol, formoterol and ipratropium bromide on exhaled nitric oxide in asthmatic patients and healthy volunteers
G. Strazda, M. Bukovskis, N. Jurka, Z. Balode, L. Balode, I. Taivans (Riga, Latvia)
| |
Comparison of asthma control test and exhaled nitric oxide to predict asthma control
Z. Yildirim, B. Bozkurt, D. Özol, A. B. Er (Ankara, Turkey)
|  |
Oxidative stress and nitric oxide metabolites in exhaled breath condensate after allergen inhalation challenge
E. Heffler, I. Badiu, C. Quaccia, F. De Renzis, S. Pizzimenti, G. Guida, C. Bucca, S. Mietta, G. Rolla, L. Brussino (Torino, Italy)
| |
Exhaled breath condensate pH for the identification of asymptomatic children at risk of asthma
M. von Jagwitz-Biegnitz, F. Pessler, M. Akmatov, C. Vogelberg (Dresden, Braunschweig, Germany)
| |
Acute exposure to second-hand smoke induces endogenous airway acidification and lung function deterioration in healthy controls
M. Minas, E. Nikolaou, E. Tagtalianidou, A. Papaioannou, V. Konstantikaki, E. Goudouva, P. Mystridou, I. Tsilioni, A. Flouris, G. Metsios, I. Koutedakis, K. Gourgoulianis, K. Kostikas (Larissa, Trikala, Greece)
| |
Effect of an inhaled short acting beta agonist on exhaled breath temperature
T. Kralimarkova, G. Garcia, T. Grigorova, A. Yañez, M. Bergna, R. Mincheva, V. Dimitrov, T. Popov (Bulgaria; La Plata, Vicente Lopez, Argentina)
| |
Increased exhaled breath temperature in subjects with non-controlled asthma
G. García, M. Bergna, E. Uribe, A. Yañez (La Plata, Vicente Lopez, Cordoba, Ciudad Autónoma de Buenos Aires, Argentina)
| |
Measurement of inflammatory factors in nasal lavage liquid in asthmatic children
J. Hong, Z. Zhang, Z. Li (China)
| |
Is quality of life related to upper and lower airways associated with inflammation?
S. Taormina, N. Scichilone, R. Santagata, G. Augugliaro, L. Giuliano, A. Sanfilippo, E. Pozzecco, A. Paternò, S. Battaglia, F. Braido, I. Baiardini, V. Bellia (Palermo, Genova, Italy)
| |
Which clinical variables best predict asthma control?
J. Bozzola, J. Arcos, C. Rodriguez, S. Tagliafico, L. Piñeyro (Montevideo, Uruguay)
| |
Assessment of disease control in outpatient asthmatics
S. Orlovic, B. Gvozdenovic, Z. Zivanovic, D. Rudinac (Smederevo, Beograd, Republic Of Serbia)
| |
Patients with mild to moderate asthma may develop clinically significant chronic obstructive pulmonary disease
S. Pejkovska, G. Breskovska, S. Arbutina, Z. Arsovski, K. Busletic (Skopje, Fyrom)
| |
Overlap asthma/COPD syndrome is associated with a poor health related quality of life
P. Kauppi, H. Kupiainen, M. Kilpeläinen, A. Lindqvist, L. Tammilehto, V. Kinnula, T. Haahtela, T. Laitinen (Helsinki, Finland)
| |